| Product NDC: | 63323-130 |
| Proprietary Name: | Doxy 100 |
| Non Proprietary Name: | DOXYCYCLINE |
| Active Ingredient(s): | 100 mg/10mL & nbsp; DOXYCYCLINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-130 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062475 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20001017 |
| Package NDC: | 63323-130-11 |
| Package Description: | 10 VIAL in 1 TRAY (63323-130-11) > 10 mL in 1 VIAL |
| NDC Code | 63323-130-11 |
| Proprietary Name | Doxy 100 |
| Package Description | 10 VIAL in 1 TRAY (63323-130-11) > 10 mL in 1 VIAL |
| Product NDC | 63323-130 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOXYCYCLINE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20001017 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | DOXYCYCLINE HYCLATE |
| Strength Number | 100 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes |